(Q36708300)

15 August 2017

1 reference

title

AAV-mediated gene transfer for retinal diseases (English)

1 reference

15 August 2017

1

Mariacarmela Allocca

1 reference

15 August 2017

Alberto Auricchio

4

1 reference

ORCID Public Data File 2021

Gabriella Cotugno

series ordinal

3

object named as

Gabriella Cotugno

1 reference

15 August 2017

Alessandra Tessitore

2

1 reference

PubMed ID

17223737

15 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

Expert Opinion on Biological Therapy

15 August 2017

1 reference

15 August 2017

6

1 reference

15 August 2017

12

1 reference

15 August 2017

1279-1294

1 reference

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

15 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Clades of Adeno-associated viruses are widely disseminated in human tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Site-specific integration by adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Molecular characterization of adeno-associated viruses infecting children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Characterization of adeno-associated virus genomes isolated from human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Adeno-associated virus expression systems for gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Production of recombinant adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Integration of adeno-associated virus (AAV) and recombinant AAV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Pseudotyped AAV vectors for constitutive and regulated gene expression in the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

New recombinant serotypes of AAV vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Identification of PDGFR as a receptor for AAV-5 transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Immune responses to gene therapy vectors: influence on vector function and effector mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Immune responses to adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Structural and functional heterogeneity of integrated recombinant AAV genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Viral serotype and the transgene sequence influence overlapping adeno-associated viral (AAV) vector-mediated gene transfer in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Efficient trans-splicing in the retina expands the utility of adeno-associated virus as a vector for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Recent advances in the molecular basis of inherited photoreceptor degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Adeno-associated viral vectors for retinal gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Adeno-associated virus-vectored gene therapy for retinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Canine inherited retinal degenerations: update on molecular genetic research and its clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Retinal degeneration mutants in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Phenotypic rescue after adeno-associated virus-mediated delivery of 4-sulfatase to the retinal pigment epithelium of feline mucopolysaccharidosis VI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Adeno-associated virus type 5: transduction efficiency and cell-type specificity in the primate retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Adeno-associated virus gene transfer to mouse retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Delivery of adeno-associated virus vectors to the fetal retina: impact of viral capsid proteins on retinal neuronal progenitor transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Regulated gene expression systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

A humanized system for pharmacologic control of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Pharmacological regulation of protein expression from adeno-associated viral vectors in the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Long-term inducible gene expression in the eye via adeno-associated virus gene transfer in nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Tetracycline-inducible viral interleukin-10 intraocular gene transfer, using adeno-associated virus in experimental autoimmune uveoretinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Sustained tetracycline-regulated transgene expression in vivo in rat retinal ganglion cells using a single type 2 adeno-associated viral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Molecular genetics of Leber congenital amaurosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Leber's congenital amaurosis: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Mutations in RPE65 cause Leber's congenital amaurosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Retinal dystrophy of Swedish briard/briard-beagle dogs is due to a 4-bp deletion in RPE65.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Gene therapy restores vision-dependent behavior as well as retinal structure and function in a mouse model of RPE65 Leber congenital amaurosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

In utero gene therapy rescues vision in a murine model of congenital blindness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Commentary: an aye for eye gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Retinitis pigmentosa GTPase regulator (RPGRr)-interacting protein is stably associated with the photoreceptor ciliary axoneme and anchors RPGR to the connecting cilium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Gene replacement therapy rescues photoreceptor degeneration in a murine model of Leber congenital amaurosis lacking RPGRIP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Rescue of photoreceptor function by AAV-mediated gene transfer in a mouse model of inherited retinal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Gene replacement therapy in the retinal degeneration slow (rds) mouse: the effect on retinal degeneration following partial transduction of the retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Long-term evaluation of retinal function in Prph2Rd2/Rd2 mice following AAV-mediated gene replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

AAV-Mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Positional cloning of the gene associated with X-linked juvenile retinoschisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Defective Discoidin Domain Structure, Subunit Assembly, and Endoplasmic Reticulum Processing of Retinoschisin are Primary Mechanisms Responsible for X-linked Retinoschisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

RS-1 Gene Delivery to an Adult Rs1h Knockout Mouse Model Restores ERG b-Wave with Reversal of the Electronegative Waveform of X-Linked Retinoschisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Prolonged recovery of retinal structure/function after gene therapy in an Rs1h-deficient mouse model of x-linked juvenile retinoschisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Cloning of the gene for ocular albinism type 1 from the distal short arm of the X chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

The ocular albinism type 1 (OA1) gene controls melanosome maturation and size

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Amelioration of both functional and morphological abnormalities in the retina of a mouse model of ocular albinism following AAV-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

AAV-mediated intravitreal gene therapy reduces lysosomal storage in the retinal pigmented epithelium and improves retinal function in adult MPS VII mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

AAV2-mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Focus on molecules: rhodopsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Gene mutations in retinitis pigmentosa and their clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Simulation of human autosomal dominant retinitis pigmentosa in transgenic mice expressing a mutated murine opsin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Genetically engineered large animal model for studying cone photoreceptor survival and degeneration in retinitis pigmentosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Ribozymes, DNAzymes and small interfering RNAs as therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

The chemical repertoire of natural ribozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Ribozyme rescue of photoreceptor cells in P23H transgenic rats: long-term survival and late-stage therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

RNAi: the nuts and bolts of the RISC machine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Ribozyme- and siRNA-mediated suppression of RGS-containing RhoGEF proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Validation in mesenchymal progenitor cells of a mutation-independent ex vivo approach to gene therapy for osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Toward a gene therapy for dominant disease: validation of an RNA interference-based mutation-independent approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Towards mutation-independent silencing of genes involved in retinal degeneration by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Gene therapy and retinitis pigmentosa: advances and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Retinal neuroprotection by growth factors: a mechanistic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Identification and characterization of rod-derived cone viability factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Two animal models of retinal degeneration are rescued by recombinant adeno-associated virus-mediated production of FGF-5 and FGF-18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Viral-mediated FGF-2 treatment of the constant light damage model of photoreceptor degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Evidence for two apoptotic pathways in light-induced retinal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Activation of caspase-3 during degeneration of the outer nuclear layer in the rd mouse retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

AAV-mediated delivery of ciliary neurotrophic factor prolongs photoreceptor survival in the rhodopsin knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Effects of adeno-associated virus-vectored ciliary neurotrophic factor on retinal structure and function in mice with a P216L rds/peripherin mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2 model of retinal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Fibroblast growth factor-2 gene delivery stimulates axon growth by adult retinal ganglion cells after acute optic nerve injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Pigment epithelium-derived factor: a potent inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Molecular and biological properties of the vascular endothelial growth factor family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Retinal and choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Generation of transgenic mice with mild and severe retinal neovascularisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Recombinant angiostatin prevents retinal neovascularization in a murine proliferative retinopathy model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Characterization of physiologically regulated vectors for the treatment of ischemic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Hypoxia-regulated transgene expression in experimental retinal and choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

Preferential silencing of a common dominant rhodopsin mutation does not inhibit retinal degeneration in a transgenic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.12.1279

10.1517/14712598.6.12.1279

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17223737